拉帕蛋白由内酶激活,以拆解26S蛋白质组
bioRxiv : the preprint server for biology
|March 10, 2025
概括
拉帕蛋白是一种新型蛋白酶组合抑制剂,在PREP裂变后转化为活性形式,诱导细胞亡和与癌症药物产生协同作用. 这一发现为研究蛋白酶体动力学提供了一个新的工具,也是一个有前途的抗癌.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由19S调节粒子 (RP) 和20S核心粒子 (CP) 形成的26S蛋白质体对细胞蛋白质平衡至关重要.
- 针对20S CP的蛋白酶体抑制剂是已知的癌症治疗方法.
研究的目的:
- 发现和描述26S蛋白酶组合的新型抑制剂.
- 研究拉帕蛋白的作用机制和治疗潜力.
主要方法:
- 全基因组的CRISPR-Cas9查,以确定重要的宿主因素.
- 生物化学试验用于研究酶活性和药物转化.
- 时间分辨率低温电子显微镜 (cryo-EM) 用于可视化分子相互作用.
- 基于细胞的测试来评估细胞亡和药物协同作用.
主要成果:
- 拉帕蛋白是一种26S蛋白酶组装抑制剂,从一种以天然产品为灵感的库中鉴定出来.
- 普罗利尔内酶 (PREP) 将拉帕蛋白切割成其活性线性形式,拉帕蛋白-L.
- 拉帕蛋白-L通过解离19S RP,破坏了26S蛋白酶全酶的完整性.
- 拉帕蛋白诱导髓瘤和白血病细胞的亡,并与现有的蛋白酶体抑制剂展现协同作用,使耐药细胞重新敏感.
结论:
- 拉帕蛋白是一种用于研究26S蛋白酶组装动态的新型化学探针.
- 拉帕蛋白独特的激活和作用机制为抗癌药物开发提供了一个有希望的新途径.
更多相关视频
09:57Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
Published on: December 17, 2016
6.6K
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
8.5K
相关概念视频
The Proteasome
8.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.4K
The Proteasome Structure
673
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
673
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Directing Proteins to the Rough Endoplasmic Reticulum
7.1K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
7.1K
Export of Misfolded Proteins out of the ER
3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
Post-translational Translocation of Proteins to the RER
5.5K
A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
5.5K
